SAN DIEGO, Calif. -- The American Association of Indian Scientists in Cancer Research honored three Indian American cancer researchers during its recent 21st annual meeting at the Horton Grand Hotel here.
Dr. Raju Kucherlapati, a Paul C. Cabot Professor of Genetics and Professor of Medicine at Harvard Medical School in Boston who is renowned for his contributions in advancing understanding the biology of cancer by using genetic/genomic approaches, received the Outstanding Scientist in Cancer Research Award.
Dr. Sanjiv S. Gambhir, a Virginia and D.K. Ludwig Professor for Clinical Investigation in Cancer Research at Stanford University School of Medicine in California, received the Lifetime Achievement Award for his contributions in advancing imaging assays to monitor fundamental cellular/molecular events in cancer patients.
Dr. Vimla Band, an Ardith and Anna Von Housen Professor and Chair Department of Genetics, Cell Biology and Anatomy at the University of Nebraska Medical Center, Omaha, received the Outstanding Woman Scientist in Cancer Research Award for her contributions in the area of breast cancer research.
In addition, the AAISCR presented Young Investigator Awards to four individuals for their outstanding work in the area of cancer research.
In the Postdoctoral/Junior Faculty category, the awards went to Dr. Amar Jyoti of the University of Kentucky, KY, and Dr. Sutapa Sinha of the Mayo Clinic in Minnesota.
In the Graduate Students category, the wards went to Nisha Hariharan of the UT Health Science Center in San Antonio, TX, and Anand Venugopal of the University of Kansas Medical Center, KS.
In a message, AAISCR president Dr. Saraswati Sukumar emphasized the need for young members of the scientific community to set up a network of peers who can guide and help them to grow and succeed in their scientific career. She highlighted the steps the organization has taken to launch a mentorship program to achieve this goal.
The highlight of the meeting was an open discussion by a panel of officers from the NCI/NIH who answered questions from the audience about the NIH grant mechanisms and the future of federal funding to support cancer research.